Home / Oil and Gas / Branch Retinal Vein Occlusion Global Clinical Trials Review, H2, 2015

Branch Retinal Vein Occlusion Global Clinical Trials Review, H2, 2015

Published: Jul 2015 | No Of Pages: 92 | Published By: GlobalData

Branch Retinal Vein Occlusion Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Branch Retinal Vein Occlusion Global Clinical Trials Review, H2, 2015" provides an overview of Branch Retinal Vein Occlusion clinical trials scenario. This report provides top line data relating to the clinical trials on Branch Retinal Vein Occlusion. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Branch Retinal Vein Occlusion 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Branch Retinal Vein Occlusion to Ophthalmology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Branch Retinal Vein Occlusion to Ophthalmology Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Branch Retinal Vein Occlusion Therapeutics Clinical Trials 27
Prominent Drugs 28
Clinical Trial Profiles 29
Clinical Trial Overview of Top Companies 29
Novartis AG 29
Clinical Trial Overview of Novartis AG 29
Allergan Plc 30
Clinical Trial Overview of Allergan Plc 30
F. Hoffmann-La Roche Ltd. 31
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 31
Suzuken Co., Ltd. 32
Clinical Trial Overview of Suzuken Co., Ltd. 32
Regeneron Pharmaceuticals, Inc. 33
Clinical Trial Overview of Regeneron Pharmaceuticals, Inc. 33
Ohr Pharmaceutical Inc. 34
Clinical Trial Overview of Ohr Pharmaceutical Inc. 34
Mid Atlantic Retina 35
Clinical Trial Overview of Mid Atlantic Retina 35
Jaguar Holding Company II 36
Clinical Trial Overview of Jaguar Holding Company II 36
Bayer AG 37
Clinical Trial Overview of Bayer AG 37
Allergan, Inc. 38
Clinical Trial Overview of Allergan, Inc. 38
Clinical Trial Overview of Top Institutes / Government 39
Baqiyatallah Medical Sciences University 39
Clinical Trial Overview of Baqiyatallah Medical Sciences University 39
Eye Laser Surgery Center 40
Clinical Trial Overview of Eye Laser Surgery Center 40
Gazi University 41
Clinical Trial Overview of Gazi University 41
Greater Houston Retina Research 42
Clinical Trial Overview of Greater Houston Retina Research 42
Hallym University Medical Center 43
Clinical Trial Overview of Hallym University Medical Center 43
IRCCS Fondazione G.B. Bietti per lo Studio e la Ricerca in Oftalmologia ONLUS 44
Clinical Trial Overview of IRCCS Fondazione G.B. Bietti per lo Studio e la Ricerca in Oftalmologia ONLUS 44
Keio University Hospital 45
Clinical Trial Overview of Keio University Hospital 45
Lions Eye Institute 46
Clinical Trial Overview of Lions Eye Institute 46
National Eye Institute 47
Clinical Trial Overview of National Eye Institute 47
Ospedale San Raffaele 48
Clinical Trial Overview of Ospedale San Raffaele 48
Five Key Clinical Profiles 49
Appendix 89
Abbreviations 89
Definitions 89
Research Methodology 90
Secondary Research 90
About GlobalData 91
Contact Us 91
Disclaimer 91
Source 92

List of Tables
Branch Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Region, 2015* 7
Branch Retinal Vein Occlusion Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Branch Retinal Vein Occlusion Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Branch Retinal Vein Occlusion Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Branch Retinal Vein Occlusion Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Branch Retinal Vein Occlusion Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Branch Retinal Vein Occlusion Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Proportion of Branch Retinal Vein Occlusion to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 14
Branch Retinal Vein Occlusion Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Branch Retinal Vein Occlusion Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Branch Retinal Vein Occlusion to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 17
Branch Retinal Vein Occlusion Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
Branch Retinal Vein Occlusion Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Branch Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Phase, 2015* 20
Branch Retinal Vein Occlusion Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 21
Branch Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Branch Retinal Vein Occlusion Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Branch Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24
Branch Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 25
Branch Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26
Branch Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 27
Branch Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 28
Branch Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 29
Branch Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan Plc, 2015* 30
Branch Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 31
Branch Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Suzuken Co., Ltd., 2015* 32
Branch Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Regeneron Pharmaceuticals, Inc., 2015* 33
Branch Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Ohr Pharmaceutical Inc., 2015* 34
Branch Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Mid Atlantic Retina, 2015* 35
Branch Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Jaguar Holding Company II, 2015* 36
Branch Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 37
Branch Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2015* 38
Branch Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Baqiyatallah Medical Sciences University, 2015* 39
Branch Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Eye Laser Surgery Center, 2015* 40
Branch Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Gazi University, 2015* 41
Branch Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Greater Houston Retina Research, 2015* 42
Branch Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Hallym University Medical Center, 2015* 43
Branch Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by IRCCS Fondazione G.B. Bietti per lo Studio e la Ricerca in Oftalmologia ONLUS, 2015* 44
Branch Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Keio University Hospital, 2015* 45
Branch Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Lions Eye Institute, 2015* 46
Branch Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2015* 47
Branch Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Ospedale San Raffaele, 2015* 48

List of Figures
Branch Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Branch Retinal Vein Occlusion Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Branch Retinal Vein Occlusion Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Branch Retinal Vein Occlusion Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Branch Retinal Vein Occlusion Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Branch Retinal Vein Occlusion Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Branch Retinal Vein Occlusion Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Proportion of Branch Retinal Vein Occlusion to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 14
Branch Retinal Vein Occlusion Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Branch Retinal Vein Occlusion Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Branch Retinal Vein Occlusion to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 17
Branch Retinal Vein Occlusion Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
Branch Retinal Vein Occlusion Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Branch Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Phase (%), 2015* 20
Branch Retinal Vein Occlusion Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 21
Branch Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Branch Retinal Vein Occlusion Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Branch Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24
Branch Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 25
Branch Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26
Branch Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 27
Branch Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 28
GlobalData Methodology 90

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +